LabGenius uses Graphcore’s IPUs to speed up drug discovery

AI-driven scientific research firm LabGenius is harnessing the power of Graphcore’s IPUs (Intelligence Processing Units) to speed up its drug discovery efforts.

LabGenius is currently focused on discovering new treatments for cancer and inflammatory diseases. The firm combines AI, lab automation, and synthetic biology for its potentially life-saving work.

Until now, the company has been using traditional GPUs for its workloads. LabGenius reports that switching to...

21 April 2022 | Applications

Shanghai uses facial recognition to help catch drug offenders

china facial recognition ai face detection artificial intelligence drugs

Facial recognition is being used in Shanghai to help catch individuals suspected of abusing pharmaceuticals.

South China Morning Post reports that Shanghai is testing facial recognition terminals in pharmacies that will verify a person’s identity prior to dispensing controlled substances.

Some legal medications can be turned into banned drugs. Cold and allergy medications, for example, often contain ephedrine which is a key component of crystal meth.

Any...

17 January 2020 | Face Recognition

AI health startup Nuritas expects to discover five new drugs by 2021

antibiotic resistance healthcare ai artificial intelligence mit research

A startup based in Ireland expects to discover five new healthcare ingredients by 2021 using artificial intelligence.

Nuritas, headquartered in Dublin, has already proven it's up to the task. The startup used AI to discover an ingredient to help treat inflammation which is expected to reach sports nutrition products by the end of 2019.

The debut ingredient was discovered as part of a collaboration with BASF, a German chemical giant. Whereas the standard to discover a new...

1 July 2019 | Healthcare